Activate Now
ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Repair Damaged Mitochondria and Reduce Fatigue Up to 45%

How One LLND Treats Lyme disease and Co-infections Using Natural Medicine

SURVEY RESULTS: Has Your Illness Affected What You Eat?

New depression diagnosis and treatment

Surprising Benefits of Cinnamon

Specific vitamin D levels linked to heart problems

A Sleep Intervention For Children With Autism: A Pilot Study

Higher vitamin D levels may be protective against acute rhinosinusitis

Real Life as a Mom with Chronic Illness

Saffron reduces oxidative stress in metabolic syndrome patients

Print Page
Email Article

Postural Orthostatic Tachycardia and ME/CFS

  [ 17 votes ]   [ 2 Comments ] • November 10, 2013

Postural Orthostatic Tachycardia and ME/CFS

Reprinted with kind permission from ME Research, Breakthrough Magazine, Autumn 2013

One of the key difficulties facing ME/CFS patients is standing, especially standing still, which can bring on symptoms such as dizziness, altered vision, nausea and fatigue. So it is certainly possible that some dysfunction of the autonomic nervous system is involved in the disease.

Since 2006, with the financial help of ME Research UK, Professor Julia Newton and her team at the School of Clinical Medical Sciences, University of Newcastle have been investigating autonomic nervous system function in ME/CFS. In fact, their scientific papers have reported autonomic dysfunction in three-quarters of ME/CFS patients, and that their blood pressure is lower and its regulation abnormal compared with healthy people.

A new scientific paper from Prof Newton’s group (published this year in the Journal of Internal Medicine) describes postural orthostatic tachycardia syndrome (POTS), an aspect of autonomic dysfunctionthat can produce substantial disability among otherwise healthy people. POTS is defined as symptoms of orthostatic intolerance (problems with standing), and it is easily diagnosed by observing the increase in heart rate on moving from lying to standing (a person with POTS has an abnormally large increase).

The team wanted to test a large group of ME/CFS patients for the presence of POTS, and to look for clinical differences between those with and without the disorder. If differences exist, it might be possible to treat and manage POTS patients as a distinct clinical subtype of ME/CFS, since we already know that this diagnosis includes a wide range of different kinds of patients.

In total, 179 consecutive patients from the Newcastle CFS Clinical Service were examined, and they underwent a series of demographic and symptom assessments, as well as autonomic function tests including heart rate variability (HRV) and left ventricular ejection time of the heart. The patients had been ill for just over 7 years on average and, overall, the prevalence of daytime sleepiness and orthostatic symptoms was high, as was physical and cognitive impairment.

In total, 24 patients (13%) had POTS, and they were younger (average age 29), less fatigued, less depressed, and reported less daytime sleepiness than the 155 (87%) without POTS. Crucially, they also had greater orthostatic symptoms and autonomic dysfunction. In fact, it was possible to predict which patients would be in the POTS group with 100% accuracy from a combination of high orthostatic intolerance and low daytime sleepiness. Of particular interest was the significantly lower HRV in the patients with POTS, indicating a greater level of autonomic nervous dysfunction in this subgroup.

These interesting results were the subject of an expert commentary in the same issue of the Journal of Internal Medicine by Prof. Jo Nijs and colleagues from Brussels. They point out that the investigation provides compelling data for a novel subgroup within the ME/CFS population, and that the results support the view of ME/CFS as a central nervous system disorder.

Clearly, it is important that POTS be recognised and managed, whether in ME/CFS or other groups of patients,since treatment can improve functional impairment and quality of life.

ME Research UK commissions and funds scientific (biomedical) investigation into the causes, consequences and treatment of ME/CFS, a debilitating illness which affects around 200,000 people in the UK and 1 million in the USA but is neither well understood nor, in many cases, properly recognised. To date, the charity has awarded more than £1 million to universities in the UK and overseas for 35 distinct scientific studies into ME/CFS, resulting in the publication of over 50 research papers.

Post a Comment

Featured Products From the ProHealth Store
Ultra ATP+, Double Strength Energy NADH™ 12.5mg Ultra EPA  - Fish Oil

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products

Article Comments Post a Comment

POTS in general population
Posted by: IanH
Nov 10, 2013
We find that about 12% of healthy women aged 17 to 40 suffer from POTS (more than 30 bpm or an increase to heart rate greater than 120 bpm within 10 minutes). Some have hypotension (I am not sure of the proportion but its around one third).

So while POTS is a subgroup of people with ME, they are probably the group with a tendency for POTS anyway.

They need test people with ME very early on in their illness because I suspect that the POTS is already present in the subgroup and worsens over time of the disease.

The cause is unknown but probably due to decreased cerebral flow which may be accentuated in ME/CFS. Some people do actually enter syncope. I believe this was some of the reason why many women fainted in the Victorian era. (Of course some may have had ME/CFS). The reason was vasovagal syncope.
Reply Reply

Posted by: IanH
Nov 10, 2013
I should have said the OTHER reason besides POTS low cerebral blood flow was vasovagal syncope.


Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Subscribe Now!
Receive up-to-date ME/CFS, Fibromyalgia & Lyme Disease treatment and research news
 Privacy Guaranteed  |  View Archives

Repair Damaged Mitochondria and Reduce Fatigue Up to 45%

Featured Products

Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function

Natural Remedies

Safely Burn Away Body Fat Safely Burn Away Body Fat
IBS, Crohn’s Disease, Colitis, and Other Digestive Disorders IBS, Crohn’s Disease, Colitis, and Other Digestive Disorders
Could a B-12 Deficiency Be Causing Your Symptoms? Could a B-12 Deficiency Be Causing Your Symptoms?
Research Links Green Tea to Weight Loss Research Links Green Tea to Weight Loss
Carry a Massage Therapist in Your Pocket Carry a Massage Therapist in Your Pocket

What is Fibromyalgia?
Fibromyalgia Diagnosis
Fibromyalgia Symptoms
Fibromyalgia Causes
Fibromyalgia Treatments
Fibromyalgia Diet
Fibromyalgia Medications
M.E. & CFS
What is M.E./CFS?
M.E./CFS Diagnosis
M.E./CFS Symptoms
M.E./CFS Causes
M.E./CFS Treatments
M.E./CFS Diet
M.E./CFS Medications
What is Lyme Disease?
Lyme Disease Diagnosis
Lyme Disease Symptoms
Lyme Disease Causes
Lyme Disease Treatments
Lyme Disease Diet
Lyme Disease Medications
M.E. & CFS
Lyme Disease
General Health
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing